Evidence map›Paper›PMID 31533953›Full record

ArticleThe Journal of cell biology2019

The PI(4)P phosphatase Sac2 controls insulin granule docking and release.

Phuoc My Nguyen, Nikhil R Gandasi, Beichen Xie, Sari Sugahara, Yingke Xu, Olof Idevall-Hagren

Open access · hybridAbstract read
In one paragraph

Article in The Journal of cell biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Insulin granule biogenesis and exocytosis.Cellular and molecular life sciences : CMLS · 2021
    Review
  8. Review
  9. Article
  10. Absence of Sac2/INPP5F enhances the phenotype of a Parkinson's disease mutation of synaptojanin 1.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  11. Membrane trafficking in health and disease.Disease models & mechanisms · 2020
    Review
  12. Membrane Heterogeneity Controls Cellular Endocytic Trafficking.Frontiers in cell and developmental biology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 3 countries.

Phuoc My NguyenDepartment of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
Nikhil R GandasiDepartment of Medical Cell Biology, Uppsala University, Uppsala, Sweden.ORCID 0000-0001-9400-6494
Beichen XieDepartment of Medical Cell Biology, Uppsala University, Uppsala, Sweden.ORCID 0000-0002-1010-0676
Sari SugaharaDepartment of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
Yingke XuDepartment of Biomedical Engineering, Key Laboratory of Biomedical Engineering of Ministry of Education, Zhejiang Provincial Key Laboratory of Cardio-Cerebral Vascular Detection Technology and Medicinal Effectiveness Appraisal, Zhejiang University, Hangzhou, China.
Olof Idevall-HagrenDepartment of Medical Cell Biology, Uppsala University, Uppsala, Sweden olof.idevall@mcb.uu.se.ORCID 0000-0002-0241-6304
Uppsala University · SEZhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Insulin granule biogenesis involves transport to, and stable docking at, the plasma membrane before priming and fusion. Defects in this pathway result in impaired insulin secretion and are a hallmark of type 2 diabetes. We now show that the phosphatidylinositol 4-phosphate phosphatase Sac2 localizes to insulin granules in a substrate-dependent manner and that loss of Sac2 results in impaired insulin secretion. Sac2 operates upstream of granule docking, since loss of Sac2 prevented granule tethering to the plasma membrane and resulted in both reduced granule density and number of exocytic events. Sac2 levels correlated positively with the number of docked granules and exocytic events in clonal β cells and with insulin secretion in human pancreatic islets, and Sac2 expression was reduced in islets from type 2 diabetic subjects. Taken together, we identified a phosphoinositide switch on the surface on insulin granules that is required for stable granule docking at the plasma membrane and impaired in human type 2 diabetes.

Indexed as

AnimalsCell MembraneCells, CulturedDiabetes Mellitus, Type 2HumansInositol Polyphosphate 5-PhosphatasesInsulinIslets of LangerhansMiceInositol Polyphosphate 5-PhosphatasesINPP5F protein, humanInsulin

Identifiers

PMID31533953
PMCPMC6829663
OpenAlexW2974774235

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.